Molsidomine Eg

Molsidomine, the active ingredient in Molsidomine Eg, is a vasodilator presented as an oral formulation for oral use. It is employed to relieve angina pectoris by improving myocardial oxygen balance in adult patients. The drug is absorbed rapidly and exerts its effect within minutes, offering symptomatic control for patients with chronic stable angina.

GNH USA supplies Molsidomine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple regions.

Molsidomine is used in the management of coronary artery disease and related anginal conditions.

Stable angina pectoris: reduces frequency and severity of chest pain episodes Chronic stable angina: improves exercise tolerance and delays onset of ischemic symptoms Ischemic heart disease: decreases myocardial oxygen demand, helping to prevent angina attacks

Molsidomine may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after dosing. - Flushing: transient warmth and redness of the skin. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Nausea: mild gastrointestinal upset. - Hypotension: low blood pressure causing faintness. - Tachycardia: increased heart rate as a compensatory response.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical intervention. - Syncope: sudden loss of consciousness. - Allergic reactions: rash, itching, or swelling of the face and throat. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hepatic enzyme elevation: abnormal liver function tests. - Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.

When prescribing Molsidomine, clinicians should consider several safety precautions to minimize risk.

- Monitor blood pressure: check for hypotension especially after the first doses. - Assess cardiac status: avoid in patients with decompensated heart failure. - Use cautiously with nitrates: combined therapy can cause additive vasodilation. - Adjust in hepatic impairment: dose may need modification in severe liver disease. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Molsidomine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Nitrates: concurrent use may cause profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe blood pressure fall. - Sodium nitroprusside: additive vasodilatory effect leading to dangerous hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals hypotension. - Calcium channel blockers: can enhance vasodilatory response. - Other antihypertensives: may require dose adjustment to avoid excessive blood pressure reduction.